| Literature DB >> 35754456 |
Zeynep Iyigundogdu1, Basak Basar2, Rachel Couvreur3, Sandeep Tamrakar3, Jaewon Yoon3, Osman G Ersoy2, Fikrettin Sahin4, Deborah Mielewski3, Alper Kiziltas3.
Abstract
The transmission of the SARS-CoV-2 coronavirus has been shown through droplets generated by infected people when coughing, sneezing, or talking in close contact. These droplets either reach the next person directly or land on nearby surfaces. The objective of this study is to develop a novel, durable, and effective disinfecting antimicrobial (antiviral, antibacterial, and antifungal) styrene-ethylene/butylene-styrene (SEBS) based thermoplastic elastomers (TPE). TPE incorporated with six different formulations was investigated for mechanical and antiviral performance. The formulations consist of a combination of zinc pyrithione (ZnPT), sodium pentaborate pentahydrate (NaB), disodium octaborate tetrahydrate (DOT), and chlorhexidine (CHX). ZnPT and DOT incorporated TPE showed a reduction of microbes such as bacteria by up to 99.99%, deactivated Adenovirus, Poliovirus, Norovirus, and reduced a strain of the coronavirus family by 99.95% in 60 min on TPE samples. Control samples had higher tensile strengths among all formulations and tensile strength decreased by around 14%, 21% and 27% for ZnPT and DOT combinations compared to control samples. The elongation at break decreased by around 7%, 9% and 12% with ZnPT and DOT combinations, where it reached minimum values of 720%, 702% and 684%, respectively. The 100% Modulus and 300% Modulus slightly increased with ZnPT and NaB combination (reaching values from 1.6 to 1.9 MPa and 2.6-2.9 MPa respectively) in comparison with control samples. The MFI also decreased with antimicrobial and antiviral additives (decreasing values from 64.8 to 43.3 g/10 min). ZnPT and NaB combination showed the lowest MFI (43.3 g/10 min) and reduced the MFI of control sample by around 33%. TPE samples containing ZnPT and DOT combination showed biocidal activity against the microorganisms tested and can be used to develop antimicrobial products for multiple touchpoints within a vehicle and micro-mobility.Entities:
Keywords: Antimicrobial and antiviral polymer; Disodium octaborate tetrahydrate; Mechanical properties; Thermoplastic elastomers; Zinc pyrithione
Year: 2022 PMID: 35754456 PMCID: PMC9212865 DOI: 10.1016/j.compositesb.2022.110060
Source DB: PubMed Journal: Compos B Eng ISSN: 1359-8368 Impact factor: 11.322
The list of microbial species tested in antimicrobial studies.
| Bacteria | Yeast | Fungi |
|---|---|---|
| Methicillin-resistant |
The list of viral species and cell lines used in antiviral studies.
| Virus | Cell Line |
|---|---|
| Human adenovirus type 5 (ATCC VR-5) | HEp-2 (ATCC CCL-23) |
| Bovine Coronavirus (ATCC VR-874) | MDBK (ATCC CCL-22) |
| Human poliovirus type 1 (RVB-1260) | HeLa (ATCC CCL-2) |
| Murine norovirus (RVB-0651) | RAW (ATCC TIB-71) |
Fig. 1Schematic representation of extruder design temperatures of corresponding extruder zones.
Injection molding parameters.
| Injection Molding Parameters | Square Plaque | Thick Plaque |
|---|---|---|
| Barrel Temperature profile (°C) | 180- 185- 185 -190 | 180- 185- 185 -190 |
| Mold Temperature (°C) | 25 | 25 |
| Injection Speed (mm/s) | Stage 1: | 25 (until 20% of shot volume) |
| Injection Pressure (bar) | 60 | 56 |
| Pack-hold Pressure (bar) | 30 | 55 |
| Pack-hold Time (s) | 20 | 30 |
| In-mold Cooling Time (s) | 30 | 25 |
| Back Pressure (bar) | 5 | 5 |
| Screw Rotation Speed (mm/s) | 40 | 40 |
Treated TPE sample compositions (wt. %).
| Control | Sample 1 | Sample 2 | Sample 3 | Sample 4 | Sample 5 | Sample 6 | |
|---|---|---|---|---|---|---|---|
| TPE | 100 | 94.11 | 91.01 | 86.94 | 82.10 | 86.04 | 80.87 |
| ZnPT | – | 3.01 | 4.01 | 3.03 | – | 3.98 | 4.05 |
| NaB | – | – | – | – | 14.92 | 9.98 | 15.08 |
| DOT | – | 2.88 | 4.98 | 10.03 | – | – | – |
| CHX | – | – | – | – | 2.98 | – | – |
Characterization of TPE-based antimicrobial compounds.
| Standard | Control | Sample 1 | Sample 2 | Sample 3 | Sample 4 | Sample 5 | Sample 6 | |
|---|---|---|---|---|---|---|---|---|
| Density (gr/cm3) | ISO 1183 1-A | 0.89 (0.001) | 0.92 (0.002) | 0.94 (0.001) | 0.95 (0.001) | 0.96 (0.001) | 0.95 (0.002) | 0.98 (0.001) |
| Melt Flow Index (gr/10min) | ISO 1133 | 64.8 (2.1) | 63.5 (1.9) | 58 (2.3) | 59.2 (2.0) | 55.6 (2.5) | 52.2 (2.8) | 43.3 (2.1) |
| Hardness - 6 mm plaka (SHORE A) | ISO 7619–1 (15 s) | 59 (0.4) | 61 (0.3) | 62 (0.4) | 64 (0.5) | 64 (0.3) | 62 (0.3) | 65 (0.3) |
| 100% Modulus (MPa) | ISO 37, DIN 53504 | 1.6 (0.01) | 1.7 (0.03) | 1.7 (0.01) | 1.8 (0.04) | 1.7 (0.07) | 1.8 (0.05) | 1.9 (0.01) |
| 300% Modulus (MPa) | ISO 37, DIN 53504 | 2.6 (0.01) | 2.8 (0.05) | 2.7 (0.08) | 2.8 (0.02) | 2.7 (0.05) | 2.8 (0.06) | 2.9 (0.02) |
| Tensile Strength at Break (MPa) | ISO 37 | 9.6 (0.013) | 8.3 (0.014) | 7.6 (0.011) | 7.0 (0.017) | 7.5 (0.015) | 8.1 (0.019) | 7.4 (0.011) |
| Elongation at Break (%) | ISO 37, DIN 53504 | 775 (10.3) | 720 (10.2) | 702 (8.2) | 684 (10.2) | 724 (9.3) | 731 (10.2) | 691 (10.3) |
| Tear Strength (Perpendicular to flow) (N/mm) | ISO 34-1 | 34.8 (0.01) | 30.8 (0.02) | 33.7 (0.01) | 33.7 (0.02) | 32 (0.03) | 33.7 (0.01) | 33.1 (0.02) |
| DSC – Tg (°C) | ISO 11357-2 | −56.07 (0.2) | −55.9 (0.1) | −54.91 (0.2) | −57.62 (0.1) | −55.09 (0.3) | −60.06 (0.2) | −55.93 (0.2) |
| DSC – Tm (°C) | ISO 11357-3 | 155.24 (0.3) | 154.72 (0.2) | 154.92 (0.2) | 154.07 (0.1) | 153.94 (0.2) | 154.55 (0.3) | 154.23 (0.2) |
| DSC – Tc (°C) | ISO 11357-3 | 103.5 (0.1) | 107.91 (0.2) | 107.16 (0.1) | 107.67 (0.1) | 106.64 (0.2) | 106.53 (0.2) | 108.17 (0.2) |
Parentheses indicate standard deviation.
Antimicrobial activity test results according to agar diffusion method.
| Sample 1 | Sample 2 | Sample 3 | Sample 4 | Sample 5 | Sample 6 | Control | |
|---|---|---|---|---|---|---|---|
| + | + | + | + | + | + | – | |
| + | + | + | – | + | + | – | |
| MRSA | + | + | + | + | + | + | – |
| + | + | + | + | + | + | – | |
| + | + | + | + | + | + | – |
Heat aging test results and odor characterization of TPE-based compounds.
| Standard | Control | Sample 1 | Sample 5 | Sample 6 | |
|---|---|---|---|---|---|
| Odor (Ford Test Method) | BO 131-03 | 2 | 2 | 4 | 4 |
| Change in Tensile strength (7 days/150 °C) (%) | ISO 188 | +12 (0.5) | +15 (2.0) | +2 (0.1) | +1 (0.1) |
| Elongation at break after ageing (7 days/150 °C) (%) | ISO 188 | +24 (2.5) | +26 (3.1) | +16 (2.3) | +15 (2.1) |
| Compression set (72 h/23 °C) (%) | ISO 815 | -21 (2.5) | -20 (2.2) | -19 (2.3) | -19 (2.2) |
| Compression set (22 h/70 °C) (%) | ISO 816 | -36.5 (2.1) | -37.5 (1.9) | -37.7 (2.4) | -38.8 (2.3) |
Parentheses indicate standard deviation.
Antimicrobial activity results according to ISO 22196:2011 method.
| Log reduction | % reduction | |||||
|---|---|---|---|---|---|---|
| Sample 1 | Sample 5 | Sample 6 | Sample 1 | Sample 5 | Sample 6 | |
| 3.69 | 3.54 | 3.68 | 99.98 | 99.97 | 99.98 | |
| 3.84 | 3.30 | 3.74 | 99.99 | 99.95 | 99.98 | |
| 3.60 | 3.65 | 3.47 | 99.97 | 99.98 | 99.97 | |
| 3.17 | 3.25 | 3.27 | 99.93 | 99.94 | 99.95 | |
Antiviral activity results of best three candidates.
| Log reduction | |||||
|---|---|---|---|---|---|
| Sample | Contact time | BCoV | AdV | PoV | MNV |
| Sample 1 | 60 min | 3.33 | 2.97 | 2.80 | 2.93 |
| Sample 5 | 60 min | 3.08 | 2.91 | 2.94 | 2.83 |
| Sample 6 | 60 min | 2.80 | 2.94 | 3.01 | 2.94 |
| % reduction | |||||
| Sample 1 | 60 min | 99.95 | 99.89 | 99.84 | 99.88 |
| Sample 5 | 60 min | 99.91 | 99.87 | 99.84 | 99.85 |
| Sample 6 | 60 min | 99.84 | 99.89 | 99.90 | 99.89 |
Antiviral activities of samples after stability tests.
| Log reduction | |||||
|---|---|---|---|---|---|
| Contact time | BCoV | AdV | PoV | MNV | |
| Sample 1 | 5 min | 1.8 | 1.8 | 2.1 | 1.8 |
| 60 min | 3.6 | 3.6 | 3.6 | 3.6 | |
| % reduction | |||||
| Sample 1 | 5 min | 98.42 | 98.42 | 99.20 | 98.42 |
| 60 min | 99.97 | 99.97 | 99.97 | 99.97 | |
Antiviral activity results against BCoV according to various virus-sample contact time.
| Sample no | Contact time | Log reduction | % reduction |
|---|---|---|---|
| 60 min | 3.33 | 99.95 | |
| 30 min | 1.66 | 97.81 | |
| Sample 1 | 10 min | 1 | 90 |
| 5 min | 1 | 90 | |
| 1 min | N/A | N/A |